Detalles de la búsqueda
1.
Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients.
Am J Transplant
; 23(3): 423-428, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906295
2.
Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk.
Clin Transplant
; 37(4): e14913, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651598
3.
Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.
Am J Transplant
; 22(9): 2254-2260, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429211
4.
6-month antibody kinetics and durability after four doses of a SARS-CoV-2 vaccine in solid organ transplant recipients.
Clin Transplant
; 37(1): e14868, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36437691
5.
Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated patients with autoimmune disease.
Clin Exp Rheumatol
; 41(5): 1202-1203, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826787
6.
Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses.
Clin Transplant
; 36(8): e14738, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670813
7.
Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series.
Clin Transplant
; 36(9): e14772, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35822545
8.
Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipients.
Clin Transplant
; 36(11): e14818, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36073912
9.
Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients.
medRxiv
; 2022 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665017
10.
Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave.
Transplantation
; 106(9): e413-e415, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35655363
11.
Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Transplantation
; 106(5): e281-e283, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066543
12.
Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Transplantation
; 106(5): e262-e263, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175241
Resultados
1 -
12
de 12
1
Próxima >
>>